<?xml version="1.0" encoding="UTF-8"?>
<p id="Par12">PrEP is effective and requires consultation with a medical clinician and clearance from labs [
 <xref ref-type="bibr" rid="CR8">8</xref>]. Though PrEP is available at any medical office, most patients get PrEP from infectious disease and primary care clinicians comfortable and effective in prescribing PrEP [
 <xref ref-type="bibr" rid="CR9">9</xref>]. These challenges are magnified as clinicians who prescribe PrEP are called to manage COVID-19. Tele-health companies already have solved this problem and can provide PrEP remotely [
 <xref ref-type="bibr" rid="CR10">10</xref>]. Pharmacies are being considered for dispensing PrEP already, with potential for providing this service with minimal clinical resource [
 <xref ref-type="bibr" rid="CR11">11</xref>, 
 <xref ref-type="bibr" rid="CR12">12</xref>]. These critical resources need to be scaled quickly. We need to identify who will lead this effort, and use our discretionary time to organize a massive push on this front. There are already models to draw from. University of Miami researchers and Latinos Salud, a South Florida-based Latino MSM HIV-agency are working with Walgreens, CVS, Navarro and Target pharmacies to build an HIV Pharmacy Network to reach Latino men in Miami Dade county. And more: Now is the time to build academic and community partnerships in preparing for implementation of low-threshold use of long-acting injectable (LAI) ART as HIV prevention in anticipation of likely FDA approval and commercial availability [
 <xref ref-type="bibr" rid="CR13">13</xref>].
</p>
